Recursion Pharmaceuticals...
6.49
0.17 (2.69%)
At close: Jan 15, 2025, 1:44 PM

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19
PE Ratio -6.25 -5.65 -16.38 -33.96 -47.73
PS Ratio 45.98 34.11 291.68 874.38 1.74K
PB Ratio 4.42 2.79 5.37 -14.47 -24.02
P/FCF Ratio -6.82 -11.2 -14.7 -57.24 -48.96
P/OCF Ratio -7.12 -16.2 -18.39 -65.73 -52.32
OCF/S Ratio -6.46 -2.1 -15.86 -13.3 -33.34
Debt / Equity Ratio 0.11 0.10 0.02 -0.08 -0.13
Quick Ratio 4.70 5.67 11.43 11.45 10.64
Current Ratio 4.70 5.68 11.46 11.67 11.43
Asset Turnover 0.07 0.06 0.02 0.01 0.02
Interest Coverage -3.61K -4.47K -61.92 -62.22 -98.33
Return on Equity (ROE) -0.71 -0.49 -0.33 0.43 0.50
Return on Assets (ROA) -0.5 -0.34 -0.29 -0.29 -0.62
Return on Capital (ROIC) -0.62 -0.41 -0.32 -0.31 -0.66
Dividend Yield n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a
Gross Profit Margin 4.46% -21.66% 8.96% -1.76K% -2.58K%
Net Profit Margin -735.99% -603.36% -1.78K% -2.57K% -3.65K%
Pretax Profit Margin -745.1% -603.5% -1.86K% -2.55K% -3.62K%
Operating Profit Margin -785.33% -619.26% -1.83K% -2.48K% -3.65K%
FCF Margin -673.77% -304.64% -1.98K% -1.53K% -3.56K%
EBITDA Margin -672.05% -573.74% -1.74K% -2.39K% -3.41K%